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RNA packagetein is similar to nucleocapsid (NC) proteins in its propensity for self-interaction
and association with RNA. Here we report on our ﬁnding that replacing MAwith NC results in the production
of wild type (wt)-level RNA and virus-like particles (VLPs). In contrast, constructs containing MA as a
substitute for NC are markedly defective in VLP production and form virions with lower densities than wt,
even though their RNA content is over 50% that of wt level. We also noted that a ΔMN mutant lacking both
MA and NC produces a relatively higher amount of VLPs than those in which MA was substituted for NC.
Although ΔMN contains approximately 30% the RNA of wt, it still exhibits virion densities equal (or very
similar) to those of wt. The data suggest that neither NC nor RNA are major virion density determinants.
Furthermore, we noted that NC(ZIP)—a NC replacement with a leucine zipper dimerization motif—produces
VLPs as efﬁciently as wt. However, the markedly reduced assembly efﬁciency of NC(ZIP) is associated with
the formation of VLPs with densities slightly lower than those of wt following MA removal, suggesting that
(a) MA is required to help the inserted leucine zipper motif perform efﬁcient Gag multimerization, and (b)
MA plays a role in the virus assembly process.
© 2008 Elsevier Inc. All rights reserved.IntroductionIn some eukaryotic cells, retroviral Gag expression by itself is
sufﬁcient to direct virus-like particle (VLP) assembly and budding
(Swanstrom and Wills, 1997). In HIV-1, the Gag precursor is a 55 kDa
polypeptide that is cleaved by viral protease into mature Gag proteins
during or soon after virus budding. The proteolytic processing of
Pr55gag yields matrix (MA; p17), capsid (CA; p24), nucleocapsid
(NC; p7), p6, and two spacer peptides (SP1 and SP2) that separate NC
from CA and p6, respectively (Swanstrom and Wills, 1997). While the
blocking of protease-mediated Gag processing has no major effect
on virus assembly and budding, it does eliminate viral infectivity
(Peng et al., 1989).
A myristylation signal and a cluster of basic residues located in the
MA amino-terminus are responsible for Gag-to-membrane binding
and plasma membrane targeting. Gag membrane binding is required
for efﬁcient Gag multimerization and virus assembly (Chang et al.,
2007; Lindwasser and Resh, 2001; Ono et al., 2000a,b; Spearman et al.,
1997, 1994; Yuan et al., 1993). Blocking myristylation by Gly
substitution or mutations in downstream basic residues can markedly
impair Gag membrane binding or plasma membrane targeting,
resulting in blocked virus particle production (Bryant and Ratner,search and Education, Taipei
pei 11217, Taiwan. Fax: +86 886
l rights reserved.1990; Freed et al., 1994; Ono and Freed,1999; Ono et al., 2000a,b; Yuan
et al., 1993; Zhou et al., 1994). The assembly domain involved in
intermolecular interactions during Gag multimerization is largely
located in the C-terminal domain of CA and the downstream NC
region, and most mutations introduced into these regions can
signiﬁcantly impair virus particle assembly. The release of virus
particles from plasma membrane is mediated by the late (L) domain
located within p6 (Gottlinger et al., 1991; Huang et al., 1995).
NC contains an I (“interaction”) domain. Since the removal of NC or
the I domain results in either diminished virus production or the
production of virions with densities below that of wt virions, the I
domain is believed to facilitate tight Gag packing by promoting
protein–protein interaction (Bennett et al., 1993; Ott et al., 2003).
Besides contributing to Gag multimerization, HIV-1 NC is thought to
play a key role in mediating viral RNA packaging (Berkowitz et al.,
1995; Cimarelli et al., 2000; Gorelick et al., 1993; Poon et al., 1996).
However, NC-dependent RNA incorporation is not essential for
retrovirus assembly, since a foreign protein sequence or leucine
zipper motif that does not associate with RNA can serve as NC
substitutes to restore VLP production to wt levels (Johnson et al.,
2002; Zhang et al., 1998). Furthermore, the neutralization of the highly
positive NC charge by substitute mutations results in signiﬁcant
reductions of virus-associated RNA with no major effects on HIV-1
assembly and budding (Wang and Aldovini, 2002; Wang et al., 2004).
This strongly suggests that the presence of viral RNA is not important
to the HIV-1 assembly process. Other researchers believe that Gag can
package non-viral RNAvia Gag–RNA interaction through theMA or NC
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addition to explaining (at least in part) why VLPs can still form under
some circumstances following NC removal, this suggestion agrees
with the proposal that RNA is an essential structural element of
retroviral cores (Muriaux et al., 2001).
A number of studies have shown that recombinant or naturally
expressed HIV-1 MA can form trimers (Hill et al., 1996; Massiah et al.,
1994) or hexamers (Alfadhli et al., 2007), suggesting that MA
possesses a self-interaction property in addition to playing a role in
RNA packaging. It has also been demonstrated that either HIV or SIV
MA expression alone is capable of producing VLPs (Gonzalez et al.,
1993; Wang et al., 1999). These ﬁndings suggest that MA is somewhat
similar to NC in its self-association characteristic and the possibility
that it promotes Gag multimerization. Here we report our ﬁndings
that MA (as a substitute for NC) is incapable of repairing the assembly
defect incurred by the NC deletion mutation, even though it does
retain its RNA packaging function. Our results indicate that RNA
packaging is insufﬁcient by itself for efﬁcient VLP assembly, and
further suggest that the appropriate positioning of MA and NC is
crucial to virus assembly.
Results
To determine whether MA confers Gag assembly when substituted
for NC, we constructed a set of HIV-1 expression vectors by replacing
NC with MA or switching the NC and MA domains. The MAII shown in
Fig. 1 contains a MA insertion in the deleted NC region and the NCII
contains a NC replacement for the MA domain. NC and/or MA were
removed either alone or in combination from the wt and above-
described constructs, yielding constructs ΔMA, ΔNC, NC/ΔNC, ΔMA/
MA, andΔMN. The backbone of all constructs is a replication-defective
HIV-1 expression vector, HIVgpt (Page et al., 1990).Fig. 1. Schematic representations of HIV-1 gag mutants. Mature processed Gag protein
fromwt and deletion (dashed lines)mutants are indicated.ΔMAcontains a replacement of
106 codons by 4 codons,withmyristylation andMA/CA cleavage signal retained. TenHIV-1
NC residues remain in the deleted region of ΔNC. Arrows indicate SP1-NC and NC-SP2
junction sites. Remaining HIV-1 NC residues in deleted regions are underlined. Italics
indicate altered or foreign amino acid residues inserted at junctions.MA sequence inserted
in deleted NC region consists of 100 residues (codons 18 to 117). Mutant capabilities
for directing VLP assembly and release are summarized as follows: ++++, release efﬁciency
comparable to wt (≧90% of wt); +++, efﬁciency 70–90% of wt; ++, efﬁciency 40–70% of wt;
+, efﬁciency below 20% of wt.Each mutant was transiently expressed in 293T cells and subjected
to Western immunoblot analysis to determine VLP assembly and
processing capability. Our results indicate that neither VLP budding
nor VLP processing was signiﬁcantly affected following the removal of
the MA central globular domain (ΔMA, Fig. 2A, lane 4) or the insertion
of NC into the deleted MA region (NCII, lane 5). In contrast, mutations
involving either the removal of NC (ΔNC, NC/ΔNC, ΔMN) or the re-
placement of NC with MA (MAII, NC/MA, ΔMA/MA) markedly affected
VLP production (lanes 3 and 6–10). The PR-mediated Gag processing
of mutants NC/ΔNC and NC/MA was also signiﬁcantly defective—
speciﬁcally, their cellular and VLP-associated p24gag were both barely
detectable. A simple explanation for the impaired Gag processing is
mutation-induced conformational changes that block cleavage sites
from accessing the PR. However, in the cases of ΔNC and MAII, sub-
stantial amounts of cellular p24gag were observed but VLP-associated
p24gag was barely detected, with unprocessed mutant precursors
representing the major Gag species in the medium samples (lanes 3
and 6 vs. lanes 13 and 16). A plausible explanation for this discrepancy
is that mutant VLPs containing processed Gag are unstable and tend to
disassemble once plasma membrane budding occurs. Similar pheno-
types have been observed with some HIV-1 NC mutants (Dawson and
Yu, 1998; Wang et al., 2004).
Since PR-mediated Gag processingmay affect VLP production level,
we reexamined the ability of each mutant to assemble and release
VLPs by expressing each mutant in a PR-inactivated backbone. Our
results (Figs. 2B and C) suggest that PR inactivation does not
signiﬁcantly improve VLP production: all mutants lacking an intact
NC domain produced VLPs at levels less than 50% that of wt, withMAII,
NC/MA, NC/ΔNC, and ΔMA/MA all producing less than 20% of wt. In
other words, MA as a substitute for NC fails to rescue the NC deletion
assembly defect, regardless of whether or not a NC is present in the
deleted MA region. Further, the results suggest that the speciﬁc
position of NC is crucial to virus assembly. Note that ΔMNwas capable
of assembling and releasing VLPs at a slightly higher level than those
mutants having a MA or NC inserted at the deleted NC or MA region
(Figs. 2A and B, lane 10 vs. lanes 6–9). This suggests that Gag
multimerization, which is primarily driven by the CA–SP1 sequence,
may be somewhat disturbed following the repositioning of MA (or NC)
in the deleted NC (or MA) region. Steric hindrance induced by the
repositioned MA or NC is a possible explanation for the impaired Gag
assembly.
Most assembly-defective mutants show a reduced membrane binding
capacity
Since cell membrane binding is required for efﬁcient Gag assembly,
we examined whether the mutations had any effect on Gag mem-
brane binding capacity by subjecting cell lysates from either wt
or mutant transfectants to membrane ﬂotation centrifugation. A
non-myristylated mutant (myr−) previously shown as being severely
defective in membrane binding and incapable of directing VLP
assembly and budding (Bryant and Ratner, 1990) served as a control.
As expected, poor myr− Gag cell membrane binding was observed—
that is, approximately 20% of total cellular Gag was membrane-
associated, compared to over 70% of wt Gag (Fig. 3). Results from
a statistical analysis indicate that all mutants whose mutations
involved a deletion of NC or a replacement of NC with MA exhibited
signiﬁcantly lower membrane binding ability compared to wt
(Fig. 3B). The exception to this rule is ΔMN, which did not show a
signiﬁcantly reduced membrane binding capacity compared with wt
(p=0.07). For most mutants, their reduced membrane binding
capacities may partly account for their defects in VLP assembly and
budding. Remarkably, the NCII showed a membrane binding capac-
ity higher than that of wt at a statistically signiﬁcant level, demon-
strating a good correlation between Gag assembly and membrane
binding ability.
Fig. 2. Assembly and processing of wild type and mutant HIV Gag proteins. (A) 293T cells were transfected with 20 μg of designated plasmid. At 48 h post-transfection, culture
supernatants and cells were collected and prepared for protein analysis as described in Materials and methods. Viral pellet samples corresponding to 50% of total samples (lanes 1 to
10) and cell lysate samples corresponding to 5% of total samples (lanes 11 to 20) were fractionated using 10% SDS-PAGE and electroblotted onto nitrocellulose ﬁlters. HIV-1 Gag
proteins were probed with a mouse monoclonal antibody directed at p24CA. Positions of HIV Gag proteins Pr55, p41, and p24/25 are indicated at left. (B) Expression and assembly of
unprocessed HIV-1 Gag mutants. 293T cells were transfected with 20 μg of PR-defective versions of indicated constructs. At 48 h post-transfection, cells and culture supernatants
were collected, prepared, and subjected toWestern immunoblotting probedwith an anti-p24CA antibody. (C) Gag proteins frommedium or cell samples were quantiﬁed by scanning
mutant and wt Pr55 band densities from immunoblots. Ratios of Pr55 levels in media to those in cells were determined for each construct and compared with wt release levels by
dividing the release ratio for each mutant by the wt ratio in parallel experiments. Error bands indicate standard deviation.
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mine the subcellular distribution of each mutant. Results indicate that
cells expressing wt Gag had heterogeneous cytoplasmic staining and
perinuclear rings, while Gag mutants lacking MA or with mutations
involving a replacement of MA with NC were mostly localized in the
perinuclear area (data not shown). In general, the subcellular distri-
bution patterns did not completely correlate with the ability to direct
virus particle assembly and budding.
Velocity sedimentation analysis of Gag mutants
Both theMA and NC domains possess considerable self-association
potential, and all of the mutations considered in this study contained
deletions or substitutions in the MA and/or NC domain. Accordingly,
all of these mutations may affect Gag multimerization. We tested this
possibility by subjecting intracellular wt and mutant Gag proteins to
velocity sedimentation analyses. Negative controls were a non-
myristylated (myr−) Gag mutant (severely defective in membrane
binding and incapable of producing VLPs) and the myristylated but
severely assembly-defective F168A mutant, which contains an alanine
substitution at Phe168 of HIV-1 CA (Chang et al., 2007). Our dataindicate that most of the wt Gag proteins were recovered at fractions 3
and 4 (Fig. 4, top panel). In contrast, the majority of myr− Gag and
nearly one-half of the F168A Gag sedimented at fractions 1 and 2
(Fig. 4, bottom two panels). These results agree with the idea that Gag
membrane binding is required for higher-order assembly product
formation. With one exception, all of the MA and NC mutants
displayed sedimentation proﬁles similar to that of wt, suggesting that
most of them are capable of some degree of self-association despite
being defective in VLP assembly. The exception was MAII, which had
noticeable portions of recovered Gag sedimented at fractions 1 and 2
(referred to as low-order oligomers). Similar results were observed in
repeat independent experiments. Results from a combination of
densitometric and statistical analyses indicate that MAII had sig-
niﬁcantly higher amounts of low-order assembly products compared
to wt (p=0.2), suggesting that self-association was more signiﬁcantly
impaired in MAII than in the other ΔNC -or ΔMA-derived mutants.
Sucrose density gradient fractionation analysis of mutant VLPs
We examined the potential effects of the mutations on virus
particle density by resuspending pellets containing VLPs in PBS buffer
Fig. 3. Membrane ﬂotation centrifugation of HIV-1 Gag proteins. (A) 293T cells were
transfected with PR-defective versions of the indicated constructs. Two days post-
transfection, cells were harvested and homogenized. Crude membrane extracted from
cell lysates was subjected to equilibrium ﬂotation centrifugation as described in
Materials and methods. In all, 10 fractions were collected from top downwards;
fraction aliquots were analyzed by Western immunoblotting using an anti-p24CA
monoclonal antibody. During ultracentrifugation, membrane-bound Gag proteins
ﬂoated to the 10–65% sucrose interface. (B) Quantiﬁcation of membrane-bound Gag
proteins. Total Gag proteins were quantiﬁed by scanning the immunoblot band
densities of fractions 1–10. Percentages of membrane-bound Gag proteins were
determined by dividing the membrane-bound Gag protein density unit (fractions 2–4)
by total Gag protein density unit and multiplying by 100. Error bands indicate standard
deviation. ⁎pb0.05, ⁎⁎pb0.01.
Fig. 4. Velocity sedimentation analysis of cytoplasmic Gag precursor complexes. 293T
cells were transfected with 20 μg of the PR-defective versions of the indicated plasmids.
Two days post-transfection, cells were homogenized and their extracted cytoplasmic
lysates were centrifuged through 25, 35, and 45% sucrose step gradients at 130,000 ×g
for 1 h. Fractions were collected from gradient tops; fraction aliquots were subjected to
10% SDS-PAGE and probed with a monoclonal antibody directed at p24CA.
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to compare wt HIV-1 particle densities in parallel, viral pellets con-
taining some mutants were spun with wt pellets through the same
gradients. As shown in Fig. 5A, wt Gag proteins banded in fractions
with sucrose densities ranging from 1.16 to 1.18 g/ml, which is con-
sistent with wild-type HIV-1 virion density. Similarly, Gag proteins
produced by the ΔMA, ΔNC, and ΔMN constructs also showed peak
fractions with densities of 1.16 g/ml. In contrast, MAII had a signiﬁcant
amount of sedimented Gag at fractions with densities below 1.16 g/ml.
Likewise, the majority of NC/MA, NC/ΔNC, and ΔMA/MA Gag was
recovered at fractions with approximate densities of 1.14–1.15 g/ml,
suggesting a Gag packing defect and/or an altered morphology of
released VLPs. The NCII Gag banded mostly at fractions with approxi-
mate densities of 1.18–1.19 g/ml, suggesting that NCII Gag was packed
more tightly than wt.The ability of the leucine zipper motif as a substitute for NC to confer VLP
assembly was signiﬁcantly reduced in the absence of MA
The above-described results indicate that MA is incapable of
replacing the HIV-1 NC assembly function even though it possesses a
propensity for self-association. As a control experiment, we replaced
NC with a sequence containing a leucine zipper dimerization domain,
and found that the resulting NC(ZIP) construct produced substantial
amounts of VLPs comparable to that of wt (Fig. 6B, lane 7). This
suggests that the leucine zipper motif is capable of replacing the NC
assembly function. However, VLP amounts produced by ΔMA/NC(ZIP)
were relatively lower than those produced by ΔMA (Fig. 6B, lane 8 vs.
lane 3), suggesting that the ability of the leucine zipper motif as an NC
substitute to confer VLP assembly requires the presence of MA. Results
from additional sucrose density centrifugation analyses indicate that
the majority of ΔMA/NC(ZIP) was sedimented at fraction 7 with a
sucrose density of 1.159 g/ml—lower than that of wt in the same
sucrose gradient (Fig. 6C). Although NC(ZIP) peaked at fraction 7 with
a sucrose density slightly lower yet close to that of wt HIV-1 virions in
parallel experiments (Fig. 6C, middle panel), both NC(ZIP) and ΔMA/
NC(ZIP) peaked at the same fraction with a density of 1.157 g/ml
(Fig. 6C, bottom panel). These results suggest that the leucine zipper
dimerization domain is not capable of completely replacing the NC
function with respect to Gag tight packing.
Effects of MA and/or NC mutations on RNA packaging
Based on the insight that MA and NC are both involved in RNA
association, we measured total virus-associated RNA for each mutant
and normalized the results to those of wt measured in parallel
experiments. Our results indicate that VLPs produced by NCII contain
RNA amounts at or near-wt levels. Data from a statistical analysis
indicate no signiﬁcant differences in ΔMA, MAII, or NC/ΔNC (p=0.068)
mutant RNA packaging efﬁciency compared to that of wt (Fig. 7). In
contrast, the RNA packaging capabilities of mutants ΔNC, NC/MA,
ΔMA/MA, ΔMN, ΔMA/NC(ZIP), and NC(ZIP) were signiﬁcantly
affected. In particular, both ΔMN and ΔMA/NC(ZIP) showed marked
defects in RNA packaging efﬁciency—approximately 30% that of wt.
Fig. 5. Sucrose density gradient fractionation of virus particles. 293T cells were
transfected with 20 μg plasmid DNA of wt or designated mutant. At 48 h post-
transfection, culture supernatants were collected, ﬁltered, and pelleted through 20%
sucrose cushions. Viral pellets were resuspended in PBS buffer and centrifuged through
20–60% sucrose gradients for 16 h as described in Materials and methods. For direct
comparisonwith wt HIV particle densities, wt viral pellets were spun through the same
sucrose density gradient with mutant pellets of MAII, ΔMA, ΔNC and ΔMN (panel A).
Equal amounts of 15 fractions were collected from top to bottom. Fraction densities
were measured and HIV-1 Gag proteins analyzed byWestern immunoblotting using an
anti-p24CA antibody. Gag protein levels in each fraction were determined with a
scanning densitometer. Sucrose densities indicated at top.
Fig. 6. Assembly and release of HIV-1 Gag containing a leucine zipper motif coding
sequence as a NC substitute. (A) Schematic representations of wt and HIV-1 Gag
mutants. NC(ZIP) and ΔMA/NC(ZIP) both contain inserts of leucine zipper domain
coding sequences in deleted NC region. HIV-1 mature Gag domains and deleted regions
(dashed lines) are indicated. (B) HIV-1 Gag mutant assembly and release. 293T cells
were transfected with wt or designated mutant. At 48–72 h post-transfection, cells and
culture supernatants were collected, prepared, and analyzed by Western immunoblot-
ting using an anti-p24CA monoclonal antibody. Relative VLP release efﬁciency for each
mutant was determined as described in the Fig. 2 caption; relative release factor values
are indicated. (C) Sucrose density gradient fractionation of virus particles. 293T cells
were transfected with 20 μg plasmid DNA from wt or designated mutants. Viral pellets
were resuspended in PBS and centrifuged through 20–60% sucrose gradients as
described in the Fig. 5 caption. To make direct comparisons with wt or NC(ZIP) particle
densities, ΔMA/NC(ZIP) pellets were pooled with wt (top panel) or NC(ZIP) pellets
(bottom panel) and centrifuged through the same gradient. Each fractionwas measured
for density and analyzed for Gag protein level by immunoblotting.
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contribute to RNA packaging, and (b) speciﬁc NC position is important
in terms of efﬁcient RNA packaging.
Discussion
A primary ﬁnding of this research is that HIV-1 MA, as a substitute
for NC, reduces the ability of a construct to assemble and release VLPs
(Fig. 3). That NCII can produce VLPs at a level comparable to wt level is
not surprising, since the MA region is capable of tolerating insertions
of heterologous or large protein sequences, providing that the N-
terminal myristylation signal remains intact (Wang et al., 2000a,b). NC
inserted into the deleted MA region may contribute to VLP assembly
by promoting multimerization and the tight packing of Gag, thus
resulting in released VLPmigration to a slightly higher density fraction
in sucrose gradients (Fig. 5B). However, in addition to being severely
defective in VLP assembly, NC/ΔNC exhibits a particle density lower
than that of wt. In addition to MAII, VLP assembly and release was
markedly impaired in other mutants in which NC was replaced with
MA. Althoughwe observed that replacingMAwith NC had no negativeeffect on VLP assembly, we also noted that switching MA and NC did
have a strong effect on VLP production. Combined, these results
suggest thatMA and NC domain order in Gag—especially NC position—
is crucial to virus assembly.
Although themajority of mutants containingMA as a NC substitute
were found to be severely assembly-defective, their particle densities
(although lower than for wt HIV-1) were within the expected range of
wt retrovirus particle densities: 1.14–1.18 g/ml. Evidence that MA as a
Fig. 7. Relative levels of virus-associated RNA. Virus-containing supernatants were
centrifuged through 20% sucrose cushions. Viral pellets were suspended in PBS buffer;
approximately 30% of the resulting suspensions were subjected toWestern immunoblot
analysis. Gag protein levels in each sample were quantiﬁed by scanning immunoblot
band densities. Remaining suspensions were subjected to RNA extraction and
quantiﬁcation as described in Materials and methods. Ratios of RNA amounts to Gag
protein levels obtained by quantifying immunoblot band densities were determined for
each mutant and normalized to those of wt in parallel experiments. Bars indicate
standard deviations. ⁎pb0.05, ⁎⁎pb0.01.
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propensity for self-association, as suggested by (Massiah et al., 1994;
Morikawa et al., 1998; Wang et al., 1999). Size limitation apparently
does not account for the inability of MA to replace NC assembly
function, since a putative dimerization domain consisting of approxi-
mately 200 coronavirus nucleocapsid residues is capable of restoring
VLP production to near-wt level when inserted into the deleted NC
region (unpublished results). It is more likely that the central MA
globular domain (as opposed to the entire MA sequence) is incapable
of self-association when positioned in the deleted NC region.
Note that the ΔMN mutation had a weaker detrimental effect on
VLP assembly compared to mutations involving MA insertions in the
NC region. Furthermore, ΔMN exhibited a wt HIV-1 virion density,
produced VLPs more efﬁciently, and possessed a greater membrane
binding capacity than its counterpart mutations containing MA in the
NC region. These results, which suggest a strong correlation between
Gag assembly ability and membrane binding capacity, are compatible
with the myristyl-switch model (Resh, 2004; Spearman et al., 1997;
Tang et al., 2004) in which multimerization is required for efﬁcient
membrane binding (Chang et al., 2007; Guo et al., 2005; Joshi et al.,
2006; Liang et al., 2003; Sandefur et al., 1998). Speciﬁc MA and
adjacent downstream CA contexts are likely required for efﬁcient Gag
multimerization; repositioning MA downstream of the CA–SP1 region
may cause the steric hindrance of Gag–Gag interaction as a result of
conformational changes. This may explain in part why the ΔMN
assembled VLPs more efﬁciently than other mutants in which MA and
NC were respectively replaced by NC and MA.
Theoretically, mutations involving NC substitutions or deletions
should affect genomic RNA packaging. While we did not speciﬁcally
measure the viral genomic content of each mutant, results from this
(Fig. 6) and previous studies (Johnson et al., 2002; Zhang et al., 1998)
indicate that VLP assembly can be restored to near-wt levels when a
leucine zipper motif is inserted into the deleted NC region, thus sug-
gesting that viral genomic RNA is at least partly dispensable for VLP
assembly. However, NC(ZIP) efﬁciency in VLP production was signiﬁ-
cantly reduced and RNA packaging capacity concomitantly reducedwhen MAwas removed (ΔMA/NC[ZIP]). In addition, the simultaneous
removal of MA and NC resulted in a reduction of released VLPs with
signiﬁcant RNA deﬁciencies. Combined, these results (a) agree with
those from previous studies indicating that both MA and NC are
involved in RNA packaging (Ott et al., 2005; Wang et al., 2003) and (b)
support the proposal that RNA is required for efﬁcient VLP assembly
(Ott et al., 2005).
Although ΔMN contained most of the MA and NC sequences, it was
still capable of RNA packaging at an efﬁciency of about 30% that of wt. To
conﬁrm an association between the measured RNA and ΔMN VLPs, we
subjected viral pellets to further isopycnic centrifugation. Aliquots of
each fractionweremeasured for RNA and analyzed for Gag protein level
using Western immunoblotting. The results indicate an association
between recovered RNA and VLPs—that is, RNA and Gag levels both
peaked in the same fraction (data not shown). This suggests thatΔMN is
still capable of RNA binding, possibly via remaining MA and/or NC
residues or another Gag sequence in the construct. At this point we
cannot state deﬁnitively that RNA is essential for VLP assembly and
release, since the ability ofmutants to package RNAdoes not completely
correlate with released VLP amounts. Although RNA is required for
Moloneymurine leukemiavirus assembly (Muriauxet al., 2001), current
evidence indicates that Gag–RNA binding is not necessary for HIV-1
virus particle assembly (Wang and Aldovini, 2002; Wang et al., 2004).
Previous studies have shown that NC deletions or mutations in
basic NC residues result in the production of virions with lower
densities (1.13–1.14 g/ml) (Bennett et al., 1993), suggesting that NC is a
key determinant of virion density. However, in the present study we
observed that ΔNC possesses a wt HIV-1 virion density of approxi-
mately 1.16 g/ml. It is unknownwhether the ten remainingNC residues
in ΔNC contribute to virion density. A similar protease-defective NC
deletion mutant that retains seven NC residues can form virions with
densities similar to wt virions without the incorporation of genomic
RNA (Ott et al., 2003). Furthermore, our ΔMN had a virion density
similar to wt HIV-1 (Fig. 5A), despite containing less than 30% of wt-
level RNA (Fig. 7). According to these results, neither the packaged RNA
level nor the presence of NC makes signiﬁcant contributions to virion
density. It may be that the presence of RNA can promote and stabilize
Gag–Gag interaction for subsequent higher-order multimerization,
while Gag packing is primarily driven by the CA domain that largely
determines virion morphology (Ako-Adjei et al., 2005). The position-
ing of an inserted dimerization domain in NC can affect proper
Gag multimerization, which may partly explain why VLPs formed by
ΔMA/NC(ZIP) possess a particle density lower than that of wt (Fig. 6C).
Materials and methods
Plasmid construction
TheΔNCmutationwas derived froma recombination of gagmutants
containing BamHI sites created at the 1940 and 2076 proviral nucleotide
positions. Sequences at the deletion juncture are nt 1935-TTTAGGATC-
CAGGCT-2081. As previously described (Chiu et al., 2002), the ΔMA
mutationwas constructed by deleting a fragment from nt 831 to nt 1147
and replacing it with a SalI linker. For MAII construction, the sequence
encoding the MA central globular domain was ampliﬁed using the
forward primer 5′-GATCGGATCCAAAAAATTCGGTTAAGGCCA-3′ and
reverse primer 5′-TCAGAGATCTCTTGCTGTGCTTTTTTCTTAC-3′. After
digestion with BamHI and BglII, the amplicon was ligated into the ΔNC
mutant. For NCII construction, the cDNA fragment encoding the NC
domain was ampliﬁed using the forward primer 5′-AATAGATCGAT-
TAATGCAGAGAG-3′ and the reverse primer 5′-TTCCGTCGACAATTAG-
CCTGTCTCTCTGTACAATCTT-3′. The ampliﬁed fragment was digested
with ClaI and SalI and ligated into the deleted MA region of ΔMA. The
other mutants shown in Fig. 1 were derived from recombinations of the
above constructs—MAII andNCII,MAII andΔMA,NCII andΔNC,ΔNCand
ΔMA yielding constructs NC/MA, ΔMA/MA, NC/ΔNC, and ΔMN,
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were PCR-ampliﬁed, digested, and ligated intoΔNC, yielding theNC(ZIP)
construct. The myristylation-minus (Myr-) mutation (in which the
second glycine residue is replaced by alanine) blocks Gag membrane
binding and virus production (Chiu et al., 2002). Allmutation constructs
were analyzed using restriction enzymes or DNA sequencing, and
each mutation was subcloned into the HIV-1 expression vector HIVgpt
(Page et al., 1990).
Cell culture and transfection
293Tcells were maintained in DMEM supplementedwith 10% fetal
calf serum. Conﬂuent 293T cells were trypsinized, split 1:10, and
seeded onto 10 cm plates 24 h before transfection. For each construct,
293T cells were transfected with 20 μg plasmid DNA via calcium
phosphate precipitation; 50 μm of chloroquine was added to enhance
transfection efﬁciency.
Western immunoblot analysis
Culture media from transfected 293T cells were ﬁltered through
0.45 μm pore-size ﬁlters prior to centrifugation through 2 ml of 20%
sucrose in TSE (10 mM Tris–HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA)
containing 0.1 mM phenylmethylsulfonyl ﬂuoride (PMSF) at 4 °C for
40 min at 274,000 ×g (SW41 rotor at 40,000 rpm). Viral pellets were
suspended in IPB (20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA,
0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 0.02% sodium
azide) containing 0.1 mM PMSF. Cells were rinsed with ice-cold
phosphate-buffered saline (PBS), scraped from each plate, collected in
1 ml PBS, and pelleted at 2500 rpm for 5 min. These pellets were
resuspended in 250 μl IPB containing 0.1 mM PMSF and subjected to
microcentrifugation at 4 °C for 15 min at 13,700 ×g to remove cell
debris. Supernatant and cell samples were mixed with equal volumes
of 2× sample buffer (12.5 mM Tris–HCl, pH 6.8, 2% SDS, 20% glycerol,
0.25% bromophenol blue) containing β-mercaptoethanol (5%) and
boiled for 5 min.
Samples were subjected to SDS-PAGE and electroblotted onto
nitrocellulose membranes (blocked with 3% gelatin in Tris-buffered
saline containing 0.05% Tween 20 [TBST]) followed by incubationwith
the primary antibody in 1% gelatin TBST for 1 h on a rocking platform
at room temperature. Next, membranes were washed three times for
10 min each with TBST and rocked for 30 min with the secondary
antibody in 1% gelatin TBST. Blots were again washed three times in
TBST for 10min each. Membrane-bound antibody-conjugated enzyme
activity was detected using an enhanced chemiluminescence (ECL)
detection system or colorimetrically. We used an anti-p24gag mono-
clonal antibody (mouse hybridoma clone 183-H12-5C) at a dilution of
1:5000 from ascites to detect HIV Gag proteins. The secondary anti-
body was a sheep anti-mouse horseradish peroxidase (HRP)-con-
jugated antibody at 1:15,000 dilution. Gag proteins were visualized
using an enhanced chemiluminescence (ECL) kit according to the
manufacturer's protocols (Pierce).
Indirect immunoﬂuorescence
A detailed description of our immunoﬂuorescence procedure can
be found in Wang et al. (1998). Brieﬂy, conﬂuent HeLa cells were split
1:80 and seeded onto coverslips 24 h prior to transfection and ﬁxed at
4 °C for 20min in ice-cold PBS containing 3.7% formaldehyde two days
post-transfection. After one washing with PBS and one with DMEM
containing 10% heat-inactivated calf serum (DMEM/calf serum), cells
were permeabilized at room temperature for 10min in PBS containing
0.2% Triton X-100, followed by incubation with primary antibodies
(mouse anti-HIV-1 CA at 1:500 dilution) for 1 h and secondary
antibodies (rabbit anti-mouse rhodamine-conjugated antibody at
1:100 dilution) for 30 min. Following each incubation, slides weresubjected to three 5-to-10 min washes with DMEM/calf serum. After
the third wash, coverslips were washed three times with PBS and
mounted in 50% glycerol in PBS for viewing. Images were taken using
an Olympus AX-80 ﬂuorescence microscope.
Membrane ﬂotation assays
At 48 h post-transfection, 293T cells were rinsed twice, pelleted in
PBS, and resuspended in TE buffer (10 mM Tris–HCl, pH 7.4, 1 mM
EDTA) containing 10% sucrose and Complete Protease Inhibitor
Cocktail (CPIC) (Roche). Cell suspensions were homogenized by
sonication followed by microcentrifugation at 3000 rpm for 5 min at
4 °C to remove nuclei and cell debris. Postnuclear supernatant (200 μl)
was mixed with 1.3 ml 85.5% sucrose in TE buffer and placed on the
bottom of a centrifuge tube and covered with layers of 7 ml 65%
sucrose and 1.5 ml 10% sucrose in TN buffer. The gradients were
centrifuged at 100,000 ×g for 16–18 h at 4 °C. Ten 1-ml fractions were
collected from the top of the centrifuge tube. Proteins in each fraction
were precipitated with ice-cold 10% trichloroacetic acid (TCA) and
analyzed by Western immunoblot.
Velocity sedimentation analysis of cytoplasmic Gag proteins
Cells were rinsed twice with PBS, pelleted, and resuspended in
1 ml TEN buffer containing CPIC followed by homogenization as
described above. Cell lysates were centrifuged at 3000 rpm for 20 min
at 4 °C. Postnuclear supernatant (500 μl) was mixed with an equal
amount of TEN buffer and applied on top of a pre-made 25–45%
discontinuous sucrose gradient consisting of TEN buffer containing
1 ml of each of 25%, 35%, and 45% sucrose. During its preparation,
gradient was centrifuged at 130,000 ×g for 1 h at 4 °C, and four 1 ml
fractions were collected from the top of each centrifuge tube. Proteins
present in the aliquots of each fractionwere precipitated with 10% TCA
and subjected toWestern blot analysis as described for the membrane
ﬂotation assay.
Sucrose density gradient fractionation
Transfected 293Tcell culture supernatant was collected, ﬁltered, and
centrifuged through a2ml20% sucrose cushion asdescribed above. Viral
pellets were suspended in PBS buffer and overlaid on a pre-made
sucrose gradient consisting of 1 ml layers of 20, 30, 40, 50, and 60%
sucrose in TSE buffer. Gradients were centrifuged in an SW55 rotor at
40,000 rpm (274,000 ×g) for 16 h at 4 °C, after which 500 μl fractions
were collected from top to bottom. Sucrose density was measured for
each fraction. Proteins in each fraction were precipitated with 10%
trichloroacetic acid (TCA) and subjected to Western immunoblotting.
Virus-associated RNA quantiﬁcation
Culture supernatant from transfected 293T cells were harvested,
ﬁltered through 0.45 μm pore-size ﬁlters, and centrifuged through a
20% sucrose cushion. Pellets were resuspended in PBS buffer and
subjected to viral RNA puriﬁcation using a QIAamp Viral RNA Mini Kit
(QIAGEN). Viral RNA was eluted with RNase-free buffer and treated
with RQ1 RNAase-free DNase (Promega) at 37 °C for 30 min prior to
quantiﬁcation.
Total viral RNA was quantiﬁed using a RiboGreen RNA Assay Kit
(Invitrogen) according to the manufacturer's protocols. Samples were
excited at 485 nm and ﬂuorescence emission intensity measured at
530 nm using a SpectraMax M5 ﬂuorescence microplate reader
(Molecular Devices). To establish a RNA standard curve, ribosomal
RNA provided in the assay kit was serially diluted and subjected to a
RiboGreen assay in parallel. Ratios of RNA concentrations to Gag band
density units on immunoblots for each mutant were determined and
normalized to that of wt.
104 C.-Y. Chang et al. / Virology 378 (2008) 97–104Statistical analysis
Data are expressed as mean±standard deviation. Differences be-
tween experimental (mutant) and control (wt) groups were assessed
using Student's t-tests. Signiﬁcance was deﬁned as pb0.05.
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